| Mathematics and Statistics | Lifetime | 71 | US 40 | 99.83 |
| Mathematics and Statistics | 2021-2025 | 54 | US 5 | 99.64 |
| Psychology and Behavioral Sciences | 2021-2025 | 539 | US 183 | 98.66 |
| Economics and Finance | 2021-2025 | 547 | US 134 | 97.93 |
| Statistics and Probability | Lifetime | 26 | US 20 | 99.77 |
| Econometrics and Quantitative Economics | Lifetime | 641 | US 362 | 99.40 |
| Clinical Psychology | Lifetime | 947 | US 573 | 98.52 |
| Statistics and Probability | 2021-2025 | 4 | US 2 | 99.68 |
| General Health Professions | 2021-2025 | 218 | US 86 | 98.46 |
| Public, Environmental and Occupational Health | 2021-2025 | 243 | US 91 | 97.91 |
| Clinical Psychology | 2021-2025 | 232 | US 88 | 98.30 |
| Econometrics and Quantitative Economics | 2021-2025 | 360 | US 65 | 98.17 |
| Statistical Methods and Bayesian Inference | Lifetime | 22 | US 17 | 99.32 |
| Advanced Causal Inference Techniques | Lifetime | 15 | US 11 | 98.91 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 213 | US 108 | 99.32 |
| Statistical Methods and Inference | Lifetime | 48 | US 31 | 99.18 |
| COVID-19 and Mental Health | Lifetime | 171 | US 40 | 98.21 |
| Healthcare Policy and Management | Lifetime | 288 | US 216 | 98.40 |
| Statistical Methods in Clinical Trials | Lifetime | 270 | US 147 | 96.52 |
| Opioid Use Disorder Treatment | Lifetime | 439 | US 302 | 96.05 |
| Health Policy Implementation Science | Lifetime | 709 | US 339 | 94.67 |
| Evaluation and Performance Assessment | Lifetime | 245 | US 139 | 93.37 |
| Prenatal Substance Exposure Effects | Lifetime | 757 | US 511 | 92.41 |
| School Choice and Performance | Lifetime | 625 | US 456 | 91.82 |
| Survey Methodology and Nonresponse | Lifetime | 787 | US 395 | 58.56 |
| Advanced Causal Inference Techniques | 2021-2025 | 2 | US 2 | 99.22 |
| COVID-19 and Mental Health | 2021-2025 | 118 | US 16 | 98.52 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 99 | US 28 | 98.52 |
| Statistical Methods and Bayesian Inference | 2021-2025 | 10 | US 1 | 98.48 |
| Statistical Methods and Inference | 2021-2025 | 39 | US 22 | 96.40 |
| Healthcare Policy and Management | 2021-2025 | 97 | US 78 | 95.76 |
| Statistical Methods in Clinical Trials | 2021-2025 | 80 | US 32 | 92.80 |
| Health disparities and outcomes | 2021-2025 | 613 | US 225 | 92.55 |
| Opioid Use Disorder Treatment | 2021-2025 | 226 | US 167 | 95.35 |
| Food Security and Health in Diverse Populations | 2021-2025 | 539 | US 314 | 88.23 |
| Prenatal Substance Exposure Effects | 2021-2025 | 244 | US 168 | 87.28 |
| Health Policy Implementation Science | 2021-2025 | 509 | US 216 | 87.66 |
| COVID-19 Pandemic Impacts | 2021-2025 | 758 | US 101 | 83.66 |
| Substance Abuse Treatment and Outcomes | 2021-2025 | 667 | US 418 | 87.03 |
| Pain Management and Opioid Use | 2021-2025 | 741 | US 383 | 72.84 |
| Meta-analysis and systematic reviews | 2021-2025 | 858 | US 172 | 70.53 |
| Homicide, Infanticide, and Child Abuse | 2021-2025 | 878 | US 297 | 34.27 |